Mirabegron 50mg

Mirabegron is a selective β3-adrenoceptor (β3-AR) agonist investigated for its effects on β-adrenergic signaling pathways and receptor-mediated regulation of cellular activity. Experimental studies have examined its interactions with β3-AR-associated cAMP signaling, Gs-protein-coupled signal transduction mechanisms, and downstream regulatory pathways. Its high selectivity for β3-adrenoceptors relative to β1- and β2-adrenoceptor subtypes makes it a valuable research tool for studies of receptor subtype pharmacology, adrenergic signaling networks, adipocyte-associated signaling mechanisms, thermogenic pathway regulation, and comparative β-adrenoceptor selectivity. Research applications include β3-adrenoceptor pharmacology, G-protein-coupled receptor signaling, metabolic pathway investigation, and adrenergic receptor subtype characterization.